Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics
(NQ:
SRPT
)
129.86
+5.41 (+4.35%)
Official Closing Price
Updated: 4:15 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sarepta Therapeutics
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
May 10, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2023
Via
Benzinga
Expert Ratings for Sarepta Therapeutics
May 03, 2023
Via
Benzinga
Sarepta Therapeutics (SRPT) Q1 2023 Earnings Call Transcript
May 03, 2023
SRPT earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Sarepta Therapeutics Earnings Preview
May 01, 2023
Via
Benzinga
This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March?
April 19, 2023
A company that seems to have seen poor market sentiment lately is NanoViricides Inc. (NYSEAMERICAN: NNVC), a pharmaceutical company specializing in the development of nanomedicine drugs for treating...
Via
Benzinga
Sarepta: More Drama Or Just More Noise?
April 14, 2023
Sarepta has a history at the FDA and recent reports indicate additional issues. What are the implications for accelerated approval and the long term prospects of Sarepta?
Via
Talk Markets
The Latest Analyst Ratings for Sarepta Therapeutics
April 14, 2023
Via
Benzinga
TD Cowen Maintains Outperform Rating for Sarepta Therapeutics: Here's What You Need To Know
March 22, 2023
Via
Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
May 05, 2023
The major indexes retreated for most of the week on banking fears,
Via
Investor's Business Daily
Analysts Says Stat News Article Adds Uncertainty To Sarepta's SRP-9001, But Offers Buying Opportunity Around The Weakness
April 13, 2023
Via
Benzinga
The Latest Analyst Ratings for Sarepta Therapeutics
March 22, 2023
Via
Benzinga
Sarepta Therapeutics' FDA Adcomm Puts Some Risk, With Potential Approval: Analyst
March 17, 2023
Via
Benzinga
FDA Staff Had Inclination Towards Rejecting Sarepta Duchenne Gene Therapy
April 13, 2023
Reviewers at the FDA were leaning toward rejecting Sarepta Therapeutics Inc's (NASDAQ: SRPT) closely watched gene therapy for Duchenne muscular dystrophy.
Via
Benzinga
Sarepta Tumbles As Report Of Internal FDA Strife Scorches Its Gene Therapy
April 13, 2023
According to a report, some staffers wanted to reject the highly watched drug.
Via
Investor's Business Daily
Why Is Merck (MRK) Stock Up Today?
April 13, 2023
Merck (MRK) stock is on the move Thursday after the pharmaceutical company got an update from the FDA concerning Keytruda.
Via
InvestorPlace
Why Is BigBear.ai (BBAI) Stock Down 5% Today?
April 13, 2023
BigBear.ai (BBAI) stock is taking a beating on Thursday after the AI company announced the details of a public stock offering.
Via
InvestorPlace
Why Is Sarepta Therapeutics (SRPT) Stock Down 12% Today?
April 13, 2023
Sarepta Therapeutics (SRPT) stock is taking a beating on Thursday following reports that the FDA was considering rejecting one of its drugs.
Via
InvestorPlace
Why Sarepta Therapeutics Stock Is Tumbling Today
April 13, 2023
Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are trading lower Thursday on the heels of a report suggesting some U.S. Food and Drug Administration staff had opposition towards Sarepta gene therapy...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 13, 2023
Via
Benzinga
2 Top Growth Stocks That Could Soar This Spring
April 06, 2023
Exciting news on the way for both of these companies could send their stock prices screaming higher.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.
Via
InvestorPlace
3 Up-and-Coming Growth Stocks to Buy Right Now
March 25, 2023
These companies are small now but could grow much larger over time.
Via
The Motley Fool
Accelerated Approval For Gene Therapies - US Health Regulator Looks To Improve Process
March 21, 2023
The FDA seeks to optimize the development of gene therapies to help get accelerated approval of therapies. The US health regulator is looking to encourage using biomarkers, such as pulse and blood...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 17, 2023
Via
Benzinga
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
March 17, 2023
A market rally is underway, but bank stocks kept tumbling.
Via
Investor's Business Daily
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 17, 2023
Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.
Via
Benzinga
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Via
Benzinga
First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday
March 17, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.